September 14, 2023 • Virtual Session

Evidence Matters 23 Logo

Executive MedTech Roundtable

placeholder
placeholder
placeholder

About Evidence Matters Executive MedTech Roundtable

Join us virtually on September 14 at 5:00 pm CDT for Evidence Matters MedTech Roundtable. This complimentary event brings together insightful experts and presents a unique opportunity for the medtech executive community to learn more about how AI and digital transformation are shaping the industry and accelerating the pace of innovation.

Roundtable Speakers

placeholder
Mark Priatel

VP Software Engineering in Software Development at DistillerSR

Q

Mark Priatel

placeholder
Chris Manrodt

Head of Data Strategy, IGT Devices at Philips
Bio

Q

Chris Manrodt

Chris Manrodt, is currently Head of Data & AI Strategy at Philips. For the last 3 years, Chris has responsibility for applications of data science in healthcare, including imaging AI, medical safety vigilance, Real-World Evidence (RWE), and more recently, applications of large language models and generative AI. He also serves on the medical devices senior staff responsible for business general management and P&L. Chris previously worked at Medtronic for over 20 years. He most recently was Staff Data Scientist and Technical Fellow, helped create Data Science as a function within Medtronic. Previous roles include Strategy, R&D, and Clinical Research. Of note, Chris was a principal creator of the Medtronic CareLink Network starting from 2001, the first IoT solution for implantable medical devices, and then led CareLink v2.0. He. Chris has a BS in Biomedical Engineering from Johns Hopkins, and an MS in Management of Technology from the University of Minnesota.
placeholder
Matthias Fink, MD

Senior Clinical Consultant at AKRA TEAM GmbH
Bio

Q

Matthias Fink, MD

Matthias Fink, MD
Senior Clinical Consultant
AKRA TEAM GmbH

Senior Clinical Consultant with Akra Team since January 2023. Consulting medical device manufacturers of all sizes on regulatory and clinical requirements with a focus on the EU MDR. Previously working as a Clinical Reviewer and Manager of the Clinical Focus Team North America for TÜV SÜD Product Service in Germany and the US. Board-certified orthopedic and trauma surgeon with 17 years of experience in orthopedic, trauma, and reconstructive surgery and extensive cardiovascular and thoracic surgery training. Presenter at national and international conferences and workshops on the clinical requirements and the implementation of the EU MDR.

Matthew M. Cooper, MD
Matthew M. Cooper, MD

Vice President, Medical Affairs, Corporate Health & Safety at 3M Health Care
Bio

Q

Matthew M. Cooper, MD MBA FACS FAsMA FCAMA

Dr. Cooper serves as Vice President, Medical Affairs, Corporate Health, & Safety for 3M Health Care. He has previously served as Chief Medical Officer Medical Solutions & Global Director of Safety for 3M Health Care, and Medical Information Director at 3M’s Health Information Systems. He is a Diplomat of the American Boards of Thoracic Surgery and Surgery, and a Fellow of the American College of Surgeons (FACS), the Aerospace Medical Association (FAsMA), and the Civil Aviation Medical Association (FCAMA). He is a graduate of Franklin & Marshall College (BA, Mathematics & Biology), New York University School of Medicine (MD), and Watson Graduate School of Management, Spears School of Business, Oklahoma State University (MBA). In addition to Residencies and Chief Residencies in General Surgery (New York University Medical Center, The University of Iowa Hospitals & Clinics) and Thoracic Surgery (Columbia Presbyterian Medical Center), he also completed a Medical Staff Fellowship in the Surgery Branch of the National Heart, Lung & Blood Institute of the National Institutes of Health (NIH) and a Fellowship in Pediatric Cardiothoracic Surgery and Transplantation at The Hospital for Sick Children, Great Ormond Street, UK. He has also studied Health Policy at the John F. Kennedy School of Government, and Comprehensive Medical Simulation, both at Harvard
University.

Dr. Cooper’s research has included pioneering methods of immunosuppression for primate cardiac xenograft transplantation. In addition to his 3M responsibilities, he serves in multiple capacities at the University of Minnesota as a member of the Industrial Advisory Board of the Institute for Engineering in Medicine, various roles with the Design for Medical Device and innovation programs, and also serves on the Board of the Fetal Therapy Foundation Think Tank.

Dr. Cooper is a Senior Aviation Medical Examiner, expert in Aviation Physiology, and a Special Consultant to the Federal Air Surgeon. He is a commercial pilot, flight instructor, and aerobatic and formation air show performer, and has flown a variety of single and multi-engine, general and military aircraft. He has been a leader in the application of aviation-based safety culture to health care.

placeholder
Mark Priatel

VP Software Engineering in Software Development at DistillerSR

Q

Peter O'Blenis

Peter is a seasoned leader in the health research space. In the early 2000s, his team developed the first commercially available literature review automation software, and he demonstrated the world’s first AI-enabled reference screening tool at the Cochrane Colloquium in 2009. His contributions to health research innovation have been recognized globally and he is a sought-after speaker in his field.

Peter has co-authored numerous peer-reviewed publications on the application of AI/NLP to the literature review process. He holds an MBA from Queen’s University and a BSc in Computer Science from Carleton University.

placeholder
Chris Manrodt

Head of Data Strategy – IGT Devices
Read more

Q

Chris Manrodt

Chris Manrodt, is currently Head of Data & AI Strategy at Philips. For the last 3 years, Chris has responsibility for applications of data science in healthcare, including imaging AI, medical safety vigilance, Real-World Evidence (RWE), and more recently, applications of large language models and generative AI. He also serves on the medical devices senior staff responsible for business general management and P&L. Chris previously worked at Medtronic for over 20 years. He most recently was Staff Data Scientist and Technical Fellow, helped create Data Science as a function within Medtronic. Previous roles include Strategy, R&D, and Clinical Research. Of note, Chris was a principal creator of the Medtronic CareLink Network starting from 2001, the first IoT solution for implantable medical devices, and then led CareLink v2.0. He. Chris has a BS in Biomedical Engineering from Johns Hopkins, and an MS in Management of Technology from the University of Minnesota.
placeholder
Matthias Fink, MD

Senior Clinical Consultant
at AKRA TEAM GmbH
Bio

Q

Matthias Fink, MD

Matthias Fink, MD
Senior Clinical Consultant at AKRA TEAM GmbH

Senior Clinical Consultant with Akra Team since January 2023. Consulting medical device manufacturers of all sizes on regulatory and clinical requirements with a focus on the EU MDR. Previously working as a Clinical Reviewer and Manager of the Clinical Focus Team North America for TÜV SÜD Product Service in Germany and the US. Board-certified orthopedic and trauma surgeon with 17 years of experience in orthopedic, trauma, and reconstructive surgery and extensive cardiovascular and thoracic surgery training. Presenter at national and international conferences and workshops on the clinical requirements and the implementation of the EU MDR.

Matthew M. Cooper, MD
Matthew M. Cooper, MD

Vice President, Medical Affairs, Corporate Health & Safety at 3M Health Care
Bio

Q

Matthew M. Cooper, MD MBA FACS FAsMA FCAMA

Dr. Cooper serves as Vice President, Medical Affairs, Corporate Health, & Safety for 3M Health Care. He has previously served as Chief Medical Officer Medical Solutions & Global Director of Safety for 3M Health Care, and Medical Information Director at 3M’s Health Information Systems. He is a Diplomat of the American Boards of Thoracic Surgery and Surgery, and a Fellow of the American College of Surgeons (FACS), the Aerospace Medical Association (FAsMA), and the Civil Aviation Medical Association (FCAMA). He is a graduate of Franklin & Marshall College (BA, Mathematics & Biology), New York University School of Medicine (MD), and Watson Graduate School of Management, Spears School of Business, Oklahoma State University (MBA). In addition to Residencies and Chief Residencies in General Surgery (New York University Medical Center, The University of Iowa Hospitals & Clinics) and Thoracic Surgery (Columbia Presbyterian Medical Center), he also completed a Medical Staff Fellowship in the Surgery Branch of the National Heart, Lung & Blood Institute of the National Institutes of Health (NIH) and a Fellowship in Pediatric Cardiothoracic Surgery and Transplantation at The Hospital for Sick Children, Great Ormond Street, UK. He has also studied Health Policy at the John F. Kennedy School of Government, and Comprehensive Medical Simulation, both at Harvard
University.

Dr. Cooper’s research has included pioneering methods of immunosuppression for primate cardiac xenograft transplantation. In addition to his 3M responsibilities, he serves in multiple capacities at the University of Minnesota as a member of the Industrial Advisory Board of the Institute for Engineering in Medicine, various roles with the Design for Medical Device and innovation programs, and also serves on the Board of the Fetal Therapy Foundation Think Tank.

Dr. Cooper is a Senior Aviation Medical Examiner, expert in Aviation Physiology, and a Special Consultant to the Federal Air Surgeon. He is a commercial pilot, flight instructor, and aerobatic and formation air show performer, and has flown a variety of single and multi-engine, general and military aircraft. He has been a leader in the application of aviation-based safety culture to health care.

Agenda

5:00 pm to 5:05 pm

Welcome Remarks by Consul General of Canada in Minneapolis, Ms. Beth Richardson

5:05 pm to 6:00 pm

Roundtable Discussion

Why Should You Attend?

Gain

Gain insights from leading medical device manufacturers on how they introduced innovative enterprise solutions that led to significant operational efficiencies and ultimately better patient outcomes.

Learn

Learn how AI is shaping enterprise evidence management solutions to accelerate innovation and time to market in the MedTech industry.

Understand

Understand the challenges medical device manufacturers are facing from pre-market approvals to post-market surveillance at various markets.

Don’t miss the

EM23 Logo Stacked

MedTech Roundtable

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

© 2024 Systematic Review & Literature Review Software by DistillerSR Inc.

DistillerSR Inc. Logo

Sitemap                   Privacy                   Terms of Use                   Accessibility

DistillerSR Inc. Logo

© 2024 Systematic Review & Literature Review Software by DistillerSR Inc.